Biocon董事长：5年内成胰岛素枢纽
2026-06-16 02:43:27
Biocon执行董事长Kiran Mazumdar-Shaw称，有信心公司在胰岛素领域的投资与产能扩张将在未来五年使其成为该药物的主要枢纽。据 Bloomberg 报道，她在接受Haslinda Amin专访时发表上述观点。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
德意志证券：日本央行或调整宽松表述Next article：
摩根士丹利下调未来数季油价预测
